Intervention not reported
Neurological sequelae at discharge · children with severe malaria
The intervention showed no clear difference in neurological sequelae at discharge (low certainty).
1 finding from 1 review
Intervention not reported
Parasite clearance time · children with severe malaria
1 finding from 1 review
Intervention not reported
Fever clearance time · children with severe malaria
1 finding from 1 review
Intervention not reported
Death · adults with severe malaria
The intervention probably leads to lower death (moderate certainty).
1 finding from 1 review
Intervention not reported
Coma resolution time · adults with severe malaria
1 finding from 1 review
Intervention not reported
Neurological sequelae at discharge · adults with severe malaria
The intervention showed no clear difference in neurological sequelae at discharge (low certainty).
1 finding from 1 review
Intervention not reported
Parasite clearance time · adults with severe malaria
1 finding from 1 review
Exacerbation: hospital 17 weeks · children with asthma
1 finding from 1 review
Asthma symptoms leading to emergency hospital visits (ED visits) · children with asthma
Effects of school‐based asthma interventions may leads to lower asthma symptoms leading to emergency hospital visits (ED visits) compared with usual care (low certainty).
1 finding from 1 review
Unplanned visit to hospital or GP due to asthma symptoms (unplanned medical visits) · children with asthma
Effects of school‐based asthma interventions probably leads to lower unplanned visit to hospital or GP due to asthma symptoms (unplanned… compared with usual care (moderate certainty).
1 finding from 1 review
Absence from school · children with asthma
1 finding from 1 review
Experience of daytime and night‐time symptoms ‐ daytime symptoms (daytime symptoms) · children with asthma
1 finding from 1 review
Use of reliever therapies, e.g. beta₂‐agonists (reliever therapies) · children with asthma
It is very uncertain whether effects of school‐based asthma interventions changes use of reliever therapies, e.g. beta₂‐agonists (reliever therapies) compared with usual care (very low certainty).
1 finding from 1 review
Health‐related quality of life · children with asthma
1 finding from 1 review
Intervention not reported
Intracranial pressure (mmHg) · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Intervention not reported
Mortality one month after the start of therapy · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Intervention not reported
Adverse effects considered as serious by either the patient or the clinician · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Intervention not reported
Disability (measured by the Glasgow Outcome Scale; higher score is better) · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Intervention not reported
Differences in quality of life ( · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Overall breast cancer incidence · women with above‐average risk of developing breast cancer
Tamoxifen probably leads to lower overall breast cancer incidence compared with placebo (moderate certainty).
1 finding from 1 review